Department of Neurology, Eunpyeong St. Mary's Hospital, The Catholic University of Korea, Seoul, Republic of Korea.
Department of Neurology, National Medical Center, Seoul, Republic of Korea.
J Alzheimers Dis. 2024;101(4):1121-1126. doi: 10.3233/JAD-231042.
Subjective cognitive decline (SCD) refers to self-reported cognitive decline in individuals with normal performance on standardized cognitive tests. Understanding the factors predicting progression from SCD to mild cognitive impairment (MCI) is crucial, as approximately 14% of SCD cases progress to dementia and about 27% develop MCI over four years.
This study aims to identify neuropsychological predictors of progression from SCD to MCI, focusing on cognitive domains assessed through neuropsychological tests.
This retrospective study at Seoul National University Bundang Hospital analyzed a cohort of 107 patients diagnosed with SCD through comprehensive assessment. Patients underwent annual neuropsychological testing, including the Digit Span Test, Boston Naming Test, Rey Complex Figure Test, Seoul Verbal Learning Test, and Stroop Test.
Annually, these patients underwent neuropsychological tests over a 5-year period; 24 progressed to MCI per NIA-AA criteria. Key predictors of MCI progression included age, ischemic heart disease, and scores from the forward digit span, delayed recall, and Boston naming tests. Lower scores in delayed recall and Boston naming tests significantly correlated with a higher risk of MCI (p < 0.001).
These findings suggest a need for targeted management of memory and language functions to monitor disease progression effectively.
主观认知下降(SCD)是指在标准化认知测试中表现正常的个体自我报告的认知下降。了解从 SCD 进展为轻度认知障碍(MCI)的预测因素至关重要,因为大约 14%的 SCD 病例会进展为痴呆,约 27%的 SCD 病例在四年内发展为 MCI。
本研究旨在确定从 SCD 进展为 MCI 的神经心理学预测因素,重点关注通过神经心理学测试评估的认知领域。
这项在首尔国立大学盆唐医院进行的回顾性研究分析了通过综合评估诊断为 SCD 的 107 名患者的队列。患者每年接受神经心理学测试,包括数字跨度测试、波士顿命名测试、 Rey 复杂图形测试、首尔言语学习测试和斯特鲁普测试。
这些患者每年接受神经心理学测试,为期 5 年;根据 NIA-AA 标准,24 例进展为 MCI。MCI 进展的主要预测因素包括年龄、缺血性心脏病以及顺向数字跨度、延迟回忆和波士顿命名测试的分数。延迟回忆和波士顿命名测试的得分较低与更高的 MCI 风险显著相关(p<0.001)。
这些发现表明需要针对记忆和语言功能进行靶向管理,以有效监测疾病进展。